CTS 2025 Q3 Earnings Beats Revenue Estimates, Net Income Falls 24.3%
Revenue
Transportation led with $58.55 million in revenue, followed by Industrial at $37.10 million. The Medical segment contributed $21.96 million, while Aerospace & Defense added $25.36 million. Total revenue reached $142.97 million, reflecting an 8.0% year-over-year increase driven by diversified market growth and the SyQwest acquisition.
Earnings/Net Income
Earnings per share (EPS) declined 21.7% to $0.47, down from $0.60 in 2024 Q3. Net income fell to $13.69 million, a 24.3% decrease from $18.08 million in the prior year. The EPS decline indicates a weak earnings performance despite revenue growth.
Post-Earnings Price Action Review
The strategy of buying CTSCTS-- stock on revenue beats and holding for 30 days faces data limitations. While Q3 2025 revenue beat estimates by 4.8%, historical price data for prior revenue beats (2020–2024) is unavailable. The stock dropped 8.59% pre-market after Q3 2025 results, underscoring volatility. With insufficient data to assess long-term effectiveness, the strategy shows limited upside potential. <visualization dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_yo1uruj4.json"></visualization>
CEO Commentary
Kieran O’Sullivan, CEO, highlighted strong diversified market growth, with 59% of Q3 revenue from industrial, aerospace, and medical segments. He emphasized strategic acquisitions and new contracts, such as a $5 million naval defense project for SyQwest.
Guidance
For FY2025, CTS narrowed sales guidance to $535–$545 million and adjusted diluted EPS to $2.20–$2.25. The company expects margin compression in Q4 but remains optimistic about long-term growth in diversified markets.
Additional News
Recent updates include a narrowed FY2025 outlook, a $5 million naval defense contract win for SyQwest, and $44 million returned to shareholders via dividends and buybacks. The company also reported $110 million in cash reserves and $91 million in long-term debt. Supply chain risks, including rare earth and semiconductor constraints, remain under monitoring.
<img src="https://cdn.ainvest.com/aigc/hxcmp/images/compress-aime_generated_1761733929998.jpg.png" style="max-width:100%;">
Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet